P0DTC2 (SPIKE_SARS2) Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)

Spike glycoprotein UniProtKBInterProInteractive Modelling

1273 aa; Sequence (Fasta) Identical sequences: Severe acute respiratory syndrome coronavirus 2: A0A679G9E9; A0A6G7K2L4

Molecule Processing
Spike protein S1
Spike protein S2
Spike protein S2'

Sequence Features

Add
 614D -> G (common polymorphism; Produces more infectious particles when pseudotyped on VSV ex vivo;)
 1214-1234Helical
 685-686Cleavage; by TMPRSS2 or furin
 815-816Cleavage; by host
 15-136
 131-166
 291-301
 336-361
 379-432
 391-525
 480-488
 538-590
 617-649
 662-671
 738-760
 743-749
 840-851
 1032-1043
 1082-1126
 33-337Betacoronavirus-like spike glycoprotein S1, N-terminal
IPR032500PF16451
 349-526Spike receptor binding domain, betacoronavirus
IPR018548PF09408
 536-592Coronavirus spike glycoprotein S1, C-terminal
IPR043607PF19209
 711-1232Spike glycoprotein S2, coronavirus
IPR002552PF01601

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab. Heteromer
7dk614-1147
Assess
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab Heteromer
7dd814-1147
Assess
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab. Heteromer
7dcx14-1147
Assess
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab Heteromer
7dk514-1147
Assess
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab. Heteromer
7dk414-1147
Assess
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab. Heteromer
7dk714-1147
Assess
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with… Heteromer
7dcc14-1147
Assess
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab. Heteromer
7dd214-1147
Assess
SARS-CoV-2 S trimer, S-open Heteromer
14×GLN; 21×PRO; 21×ARG; 33×THR; 11×CYS; 36×LEU; 24×LYS; 37×ASN; 32×VAL; 22×ALA; 26×TYR; 23×GLY; 22×ASP; 36×PHE; 35×SER;HIS;TRP; 23×ILE; 16×GLU;MET;7dk314-1147
Assess
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein Heteromer
15×NAG; 16×NAG;7cwn14-1147
Assess
SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail Heteromer
15×NAG; 16×NAG;7cws14-1147
Assess
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail Heteromer
15×NAG; 16×NAG;7cwu14-1147
Assess
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed st… Heteromer
14×NAG; 16×NAG;7cwm14-1147
Assess
SARS-CoV-2 S-ACE2 complex Heteromer
Q9BYF1;
18×NAG; 36×NAG;7df414-1147
Assess
S protein of SARS-CoV-2 in complex bound with 4A8 Heteromer
NAG; 23×NAG; 25×NAG;7c2l14-1146
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction Heteromer
Q9BYF1;
7a9514-1146
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction Heteromer
Q9BYF1;
7a9614-1146
Assess
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound Heteromer
Q9BYF1;
7a9714-1146
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound Heteromer
Q9BYF1;
23×NAG;ZN;7a9414-1146
Assess
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound Heteromer
Q9BYF1;
7a9814-1146
Assess
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1) Heteromer
12×NAG; 39×NAG;6zxn14-1146
Assess
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment Heteromer
12×NAG;NAG; 36×NAG;7jw015-1147
Assess
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up confor… Heteromer
NAG; 45×NAG;7a2914-1146
Assess
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) Heteromer
NAG; 45×NAG;7a2514-1146
Assess
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment Heteromer
18×NAG;NAG; 30×NAG;7k4315-1140
Assess
SARS-CoV-2 spike in complex with LCB1 (2RBDs open) Heteromer
13×NAG; 33×NAG;7jzl27-1150
Assess
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 Heteromer
Q9BYF1;
NAG; 53×NAG;7kmz26-1149
Assess
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
Q9BYF1;
NAG; 55×NAG;7kms26-1149
Assess
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
Q9BYF1;
NAG; 48×NAG;7knh26-1149
Assess
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
Q9BYF1;
NAG; 56×NAG;7kni26-1149
Assess
SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab Heteromer
15×NAG; 30×NAG;7cak25-1147
Assess
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab Heteromer
15×NAG; 30×NAG;7cai25-1147
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
Q9BYF1;
NAG; 46×NAG;7knb26-1148
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 Heteromer
Q9BYF1;
NAG; 44×NAG;7kne26-1148
Assess
SARS-CoV-2 spike in prefusion state Heteromer
16×NAG;NAG;NAG; 18×NAG;MAN;DMS;6zow27-1148
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab f… Heteromer
NAG;NAG;NAG;NAG; 30×NAG;6xcm27-1147
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab f… Heteromer
NAG;NAG;NAG; 24×NAG;6xcn27-1147
Assess
Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex Heteromer
20×NAG; 26×NAG;6z4327-1147
Assess
SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab Heteromer
13×NAG; 23×NAG;6zdh27-1147
Assess
SARS CoV2 Spike ectodomain with engineered trimerized VH binder Heteromer
7jwb27-1147
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
13×NAG; 34×NAG;7k8w27-1147
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
15×NAG; 27×NAG;7k8s27-1147
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
13×NAG;NAG;NAG; 33×NAG;7k8z27-1147
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
10×NAG; 21×NAG;7k8v27-1147
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
15×NAG; 30×NAG;7k8t27-1147
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
NAG;NAG;7k8u27-1147
Assess
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 Heteromer
18×NAG; 27×NAG;7kkl27-1147
Assess
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound Heteromer
Q9BYF1;
17×NAG; 36×NAG;7kj227-1147
Assess
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound Heteromer
Q9BYF1;
20×NAG; 40×NAG;7kj327-1147
Assess
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound Heteromer
Q9BYF1;
24×NAG; 42×NAG;7kj427-1147
Assess
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 Heteromer
12×NAG; 30×NAG;7kkk27-1147
Assess
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12 Heteromer
NAG;NAG;NAG;NAG; 25×NAG;7l0627-1147
Assess
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D r… Heteromer
10×NAG;NAG;NAG;NAG; 32×NAG;7l0927-1147
Assess
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12 Heteromer
10×NAG;NAG;NAG;NAG; 31×NAG;7l0227-1147
Assess
H11-H4 bound to Spike Heteromer
20×NAG; 26×NAG;6zhd27-1147
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
28×NAG;7k8x27-1147
Assess
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
23×NAG;7k8y27-1147
Assess
BD23-Fab in complex with the S ectodomain trimer Heteromer
NAG;NAG; 32×NAG;7byr27-1146
Assess
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs Heteromer
NAG; 31×NAG;7chh27-1146
Assess
SARS-CoV-2 spike in complex with LCB3 (2RBDs open) Heteromer
13×NAG; 33×NAG;7jzn27-1146
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… Heteromer
33×NAG;7k9027-1146
Assess
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 Heteromer
NAG;NAG;NAG; 36×NAG;6xey27-1146
Assess
S protein of SARS-CoV-2 in complex bound with T-ACE2 Heteromer
Q9BYF1;
35×NAG; 34×NAG;7ct527-1146
Assess
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment Heteromer
15×NAG; 33×NAG;7k4n27-1145
Assess
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open) Heteromer
11×NAG; 36×NAG;7jv427-1145
Assess
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) Heteromer
12×NAG; 36×NAG;7jv627-1145
Assess
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment Heteromer
12×NAG;NAG; 33×NAG;7jvc27-1145
Assess
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4) Heteromer
NAG; 27×NAG;7kl927-1145
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab f… Heteromer
12×NAG;NAG; 33×NAG;6wps27-1140
Assess
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab f… Heteromer
10×NAG;NAG;NAG; 35×NAG;6wpt27-1140
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) Heteromer
Q9BYF1;
NAG;NAG;ZN;7a9214-676
Assess
Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement) Heteromer
NAG;7a5s33-676
Assess
Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement) Heteromer
NAG;7a5r33-579
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
Q9BYF1;
NAG;NAG;ZN;7a91322-590
Assess
Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing… Heteromer
NAG;6xe1326-532
Assess
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab Heteromer
DMS;MLI;NAG;1PE;6yla330-529
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 Heteromer
NAG;6xc4334-532
Assess
Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by st… Heteromer
NAG;7jx3332-529
Assess
H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex Heteromer
NAG;6z2m332-528
Assess
Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A … Heteromer
NAG;PO4;6zer333-529
Assess
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab (crystal for… Heteromer
6ym0333-529
Assess
Soaking competent crystal form of the SARS-CoV-2 Receptor Binding Domain (RBD):CR3022 complex. Heteromer
NAG;6zlr333-528
Assess
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 Heteromer
Q9BYF1;
NAG;NAG;NAG;NAG;ZN;SO4;7dmu332-527
Assess
H11-D4 complex with SARS-CoV-2 RBD Heteromer
NAG; 12×EDO;ACT;6yz5334-528
Assess
Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody Heteromer
NAG;7bz5334-528
Assess
H11-H4 complex with SARS-CoV-2 Heteromer
NAG;SO4;6zbp334-528
Assess
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab) Heteromer
NAG;7kfv334-528
Assess
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-F10 Fab) Heteromer
NAG;7kfy334-528
Assess
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-C2 Fab) Heteromer
NAG;7kfx334-528
Assess
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 Heteromer
Q9BYF1;
NAG;ZN;6lzg333-527
Assess
Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex wi… Heteromer
NAG;CL;MG;6zcz333-527
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022 Heteromer
NAG;6xc3334-528
Assess
Structure of sybody MR17 in complex with the SARS-CoV-2 S receptor-binding domain (RBD) Heteromer
NAG;GOL;7c8w333-527
Assess
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab) Heteromer
NAG;7kfw334-528
Assess
Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD Heteromer
NAG;7c01333-527
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 Heteromer
NAG;6xc7334-528
Assess
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutral… Heteromer
NAG;7jmw334-528
Assess
Structure of sybody MR17-K99Y in complex with the SARS-CoV-2 S Receptor-binding domain (RBD) Heteromer
NAG;GOL;7can333-527
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutra… Heteromer
NAG;7k9z333-527
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022 Heteromer
GOL;SO4;NAG;6w41333-527
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 Heteromer
NAG;6xc2334-528
Assess
H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex Heteromer
NAG;6yz7334-528
Assess
Ternary complex CR3022 H11-H4 and RBD (SARS-CoV-2) Heteromer
6zh9334-528
Assess
Structure of the SARS-CoV-2 spike S1 protein in complex with CR3022 Fab Heteromer
6yor334-528
Assess
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD Heteromer
Q56H28;
ZN;7c8d333-527
Assess
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of t… Heteromer
NAG;7jva333-527
Assess
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody Fab Heteromer
NAG;7cjf334-527
Assess
Structure of sybody SR4 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) Heteromer
GOL;NAG;7c8v334-527
Assess
Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab Heteromer
NAG;7chb333-526
Assess
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 Heteromer
Q9BYF1;
ZN;CL;NAG;6m0j333-526
Assess
Crystal structure of the SARS-CoV-2 RBD in complex with BD-604 Fab and BD-368-2 Fab Heteromer
7chf333-526
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-… Heteromer
NAG;SO4;6xkp334-527
Assess
crystal structure of SARS-CoV-2 antibody with RBD Heteromer
NAG;7bwj333-526
Assess
Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD Heteromer
NAG;7cdi333-526
Assess
Crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) with nanobody Nb20 Heteromer
CAC;7jvb334-527
Assess
Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD Heteromer
NAG;7cdj333-526
Assess
Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab and BD-368-2 Fab Heteromer
7che333-526
Assess
Association of two complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab Heteromer
NAG;6zfo333-526
Assess
Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies Heteromer
NAG;6xdg333-526
Assess
Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A … Heteromer
NAG;6zdg333-526
Assess
The interface of H014 Fab binds to SARS-CoV-2 S Heteromer
7cah334-527
Assess
SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) Heteromer
NAG;7jzm334-527
Assess
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of … Heteromer
NAG;7k45334-527
Assess
SARS-CoV-2 spike protein RBD and P17 fab complex Heteromer
7cwo334-527
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2… Heteromer
NAG;7jmo334-526
Assess
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-604 Fab Heteromer
7ch4334-526
Assess
SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) Heteromer
NAG;7jzu334-526
Assess
ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2… Heteromer
Q9BYF1;
NAG;NAG;7kmb335-526
Assess
Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody… Heteromer
NAG;7k8m334-517
Assess
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab Heteromer
7ch5334-516
Assess
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab and BD-368-2 Fab Heteromer
7chc334-516
Assess
The 2019-nCoV RBD/ACE2-B0AT1 complex Heteromer
Q695T7; Q9BYF1;
14×NAG;NAG; 10×NAG;LEU;ZN;6m17336-518
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2… Heteromer
NAG;7jmp338-516
Assess
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-… Heteromer
NAG;6xkq338-514
Assess
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 Heteromer
P59594; Q9BYF1;
NAG;NAG;ZN;CL;EDO;NAG;6vw1455-518
Assess
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of … Heteromer
7jv2443-501
Assess
Crystal structure of neuropilin-1 b1 domain in complex with SARS-CoV-2 S1 C-end rule (CendR) peptide Heteromer
O14786;
PEG;7jjc683-685
Assess
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimershomo-6-mer 76×NAG;NAG;NAG; 16×NAG;7jjj14-1146
Assess
Structure of the 2019-nCoV HR2 Domainhomo-4-mer 6lvn1169-1203
Assess
Distinct conformational states of SARS-CoV-2 spike proteinhomo-3-mer 21×NAG;NAG;NAG;NAG; 21×NAG;6xr814-1162
Assess
SARS-Cov2 S protein at close statehomo-3-mer 7ddd14-1147
Assess
SARS-Cov2 S protein at open statehomo-3-mer 7ddn14-1147
Assess
SARS-CoV-2 S trimer, S-closedhomo-3-mer 24×NAG; 30×NAG;7df314-1147
Assess
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erecthomo-3-mer 6zgg14-1146
Assess
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformationhomo-3-mer 6zgh14-1146
Assess
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformationhomo-3-mer 27×NAG; 24×NAG;6zgi14-1146
Assess
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformationhomo-3-mer 30×NAG; 21×NAG;6zge14-1146
Assess
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)homo-3-mer 45×NAG;NAG;VCG;EIC;7jji14-1146
Assess
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erecthomo-3-mer 7a9314-1146
Assess
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Lock…homo-3-mer 12×NAG; 39×NAG;EIC;6zp215-1141
Assess
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383…homo-3-mer 12×NAG; 39×NAG;6zoz15-1140
Assess
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down)homo-3-mer 12×NAG; 36×NAG;6xf527-1152
Assess
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDshomo-3-mer 15×NAG; 33×NAG;6zwv27-1151
Assess
SARS CoV-2 Spike protein, Closed conformation, C3 symmetryhomo-3-mer NAG; 20×NAG;EIC;6zb515-1139
Assess
SARS CoV-2 Spike protein, Closed conformation, C1 symmetryhomo-3-mer NAG; 25×NAG;EIC;6zb415-1139
Assess
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibodyhomo-3-mer 15×NAG; 30×NAG;7cab25-1147
Assess
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation)homo-3-mer 16×NAG;NAG;NAG; 18×NAG;MAN;DMS;6zp527-1148
Assess
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation)homo-3-mer 16×NAG;NAG;NAG; 18×NAG;MAN;DMS;6zp727-1148
Assess
Structure of the prefusion SARS-CoV-2 spike glycoproteinhomo-3-mer 11×NAG; 27×NAG;6z9727-1147
Assess
SARS-CoV-2 spike ectodomain structure (open state)homo-3-mer 12×NAG; 35×NAG;6vyb27-1147
Assess
SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimerhomo-3-mer 6x2c27-1147
Assess
Structure of SARS-CoV-2 Spike Protein Trimer (single Arg S1/S2 cleavage site) in Closed Statehomo-3-mer 12×NAG; 36×NAG;6zp027-1147
Assess
Consensus structure of SARS-CoV-2 spike at pH 5.5homo-3-mer 14×NAG; 28×NAG;6xm027-1147
Assess
SARS-CoV-2 u1S2q 2 RBD Up Spike Protein Trimerhomo-3-mer 6x2b27-1147
Assess
Structure of the SARS-CoV-2 spike glycoprotein (closed state)homo-3-mer 15×NAG; 33×NAG;6vxx27-1147
Assess
Structure of SARS-CoV-2 spike at pH 5.5, all RBDs downhomo-3-mer 16×NAG; 26×NAG;6xm527-1147
Assess
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 1homo-3-mer 17×NAG; 26×NAG;6xm327-1147
Assess
SARS-CoV-2 u1S2q 1 Up RBD Spike Protein Trimerhomo-3-mer 6x2a27-1147
Assess
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic A…homo-3-mer 12×NAG; 33×NAG;6x6p27-1147
Assess
Structure of SARS-CoV-2 spike at pH 4.0homo-3-mer 15×NAG; 32×NAG;6xlu27-1147
Assess
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2homo-3-mer 18×NAG; 25×NAG;6xm427-1147
Assess
SARS-CoV-2 rS2d Down State Spike Protein Trimerhomo-3-mer 6x2927-1147
Assess
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)homo-3-mer 12×NAG; 35×NAG;6xf627-1147
Assess
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA…homo-3-mer 15×NAG; 33×NAG;7ke827-1147
Assess
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and…homo-3-mer NAG; 15×NAG;7a4n27-1147
Assess
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-…homo-3-mer 12×NAG; 35×NAG;7kdl27-1147
Assess
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabi…homo-3-mer 15×NAG; 33×NAG;7kdi27-1147
Assess
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D…homo-3-mer 12×NAG; 35×NAG;7keb27-1147
Assess
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)homo-3-mer 58×NAG;7kdh27-1147
Assess
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA…homo-3-mer 15×NAG; 33×NAG;7ke427-1147
Assess
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA…homo-3-mer 15×NAG; 33×NAG;7kdk27-1147
Assess
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-…homo-3-mer 12×NAG; 34×NAG;7kea27-1147
Assess
SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)homo-3-mer 15×NAG; 33×NAG;7kdg27-1147
Assess
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabili…homo-3-mer 12×NAG; 35×NAG;7kdj27-1147
Assess
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and…homo-3-mer 10×NAG; 10×NAG;7ad127-1147
Assess
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA…homo-3-mer 15×NAG; 33×NAG;7ke627-1147
Assess
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-…homo-3-mer 12×NAG; 35×NAG;7ke927-1147
Assess
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-…homo-3-mer 12×NAG; 33×NAG;7kec27-1147
Assess
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA…homo-3-mer 15×NAG; 33×NAG;7ke727-1147
Assess
SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD up conformationhomo-3-mer 12×NAG; 35×NAG;7kj527-1147
Assess
Structure of SARS-CoV-2 spike at pH 4.5homo-3-mer 17×NAG; 30×NAG;7jwy27-1147
Assess
SARS-CoV-2 HexaPro S One RBD uphomo-3-mer 11×NAG; 28×NAG;6xkl27-1146
Assess
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain uphomo-3-mer 17×NAG; 27×NAG;6vsb27-1146
Assess
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Clos…homo-3-mer 15×NAG; 33×NAG;6zp127-1140
Assess
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x2 disulphide-bond mutant, G413…homo-3-mer 15×NAG; 33×NAG;6zox27-1140
Assess
Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformationhomo-3-mer NAG; 33×NAG;6x7927-1140
Assess
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383…homo-3-mer 12×NAG; 36×NAG;6zoy27-1140
Assess
Cryo-EM structure of SARS-CoV-2 Spike ectodomainhomo-3-mer NAG;NAG;NAG;NAG; 23×NAG;7cn927-1140
Assess
SARS-CoV-2 Spike D614G variant, minus RBDhomo-3-mer 6xs627-1137
Assess
Distinct conformational states of SARS-CoV-2 spike proteinhomo-3-mer NAG;NAG;NAG;NAG;MAN;6xra703-1197
Assess
Structure of post fusion core of 2019-nCoV S2 subunithomo-3-mer PG4;ZN;6lxt912-1180
Assess
Crystal structure of post fusion core of 2019-nCoV S2 subunithomo-3-mer 6m1v917-966
Assess

Homology models

Oligo-stateQMEANTemplateRangeSeq id (%)Ligands
Heteromer
Q9BYF1;
-0.23 6m0j.1.B333-526
100.00ZN;
Assess
Heteromer
Q9BYF1;
-0.45 6lzg.1.B333-527
100.00NAG;ZN;
Assess
Heteromer
Q9BYF1;
-0.69 6vw1.2.B331-527
96.19EDO;
Assess
Heteromer
Q9BYF1;
-1.95 7a94.1.A14-1146
99.89NAG;ZN;
Assess
Heteromer
Q9BYF1;
-3.98 6acg.1.A14-1137
84.55
Assess